Processing the protocol with id 152
##########################################
Searching for the item "2a Scientific background and explanation of rationale..."
This part was defined, probably, at this section: 1. INTRODUCTION 
I have not found anything about the rationales from titles, lets take a look for the introduction
Rationales: NOT FOUND
I have not found anything about the previous studies from titles, lets take a look for the introduction
Previous studies: FOUND
Occurrences in the text:
10248	Phase II 	"... This finding is consistent with the Phase II data for  gefitinib, extensive..."
##########################################
Searching for the item "2b Specific objectives or hypotheses"...
This part was defined, probably, at this section: 2. STUDY OBJECTIVES 
Primary objectives: NOT FOUND
For more information about the secondary objectives, go to sections:
2.2 The secondary objectives of the study are: 
Objectives: FOUND
Occurrences in the text:
12788	investigate 	"...   To investigate baseline biomarker data in consenting patients to ascertain if there  are any..."
11489	compare 	"... s to compare gefitinib with carboplatin / paclitaxel  doublet chemotherapy given as first line treatment..."
11733	compare 	"...   to compare the randomized treatment arms in terms of overall survival,  and to compare gefitinib with..."
11809	compare 	"... d to compare gefitinib with carboplatin / paclitaxel doublet chemotherapy given as first line  treatment..."
12622	compare 	"...   To compare gefitinib with carboplatin / paclitaxel doublet chemotherapy given as  first line treatment..."
##########################################
Searching for the item "3a Description of trial design (such as parallel, factorial) including allocation ratio"...
This part was defined, probably, at this section: 3. STUDY PLAN AND PROCEDURES 
I found the following features of the study:
placebo controlled
prospective
randomised
3 Both treatment arm
1 To allow for possible dose delays on both arm
open label
Phase III
phase 3
phase III
placebo  controlled
two treatment  regimen
0  Platinum based chemotherapy has become established as the standard first line treatment for  advanced NSCLC with no evidence of a difference in the effectiveness of one regimen
Placebo: found -> randomized-controlled study
Occurrences in the text:
48322	placebo	 "... Notably, in a large placebo  controlled phase 3..."
48709	placebo	 "... from this large phase III  placebo controlled study..."
48907	placebo	 "... survival relative to  placebo, although the..."
49313	placebo	 "... therapy compared with placebo for never smokers of..."
49511	placebo	 "... for patients receiving placebo to 8.9 months for ..."
Allocation ratio: 1:1, 1:1, 1:1
##########################################
Checking for the item "4a Eligibility criteria for participants..."
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item "5 Interventions for each group with sufficient details to allow replication, including how and when they were actually administered"
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item “7a how sample size was determined”...
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Searching any information about a randomzation
This part was defined, probably, at this section: 4.1 Progression Free Survival (PFS) is defined as the time from randomisation to the first 
##########################################
Checking for the item “11a  if done, who was blinded after assignment to interventions (eg, participants, care providers, those assessing outcomes) and how.”
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item “12a  statistical methods used to compare groups for primary and secondary outcomes”
This part was defined, probably, at this section: 6. STATISTICAL METHODS AND DETERMINATION OF 
I found the following methods:
141502 	 kaplan meier 	 "... ill also be displayed graphically using Kaplan Meier plots (Kaplan EL et al..."
